Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 450, 1001-1009 (13 December 2007) | doi:10.1038/nature06526; Published online 12 December 2007
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
nature jobs
Bioprocess Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Flash Animator
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Review Article Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
James A. Wells1,2 & Christopher L. McClendon3
Abstract
Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-molecule drugs that disrupt protein–protein interactions is an enormous challenge. Several recent success stories, however, indicate that protein–protein interfaces might be more tractable than has been thought. These studies discovered small molecules that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein–protein interactions. Remarkably, these small molecules bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner. Some of these small molecules are now making their way through clinical trials, so this high-hanging fruit might not be far out of reach.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Ending the prolonged life of cancer cellsNature Chemical Biology News and Views (01 Jun 2005)
Death by design: the big debut of small moleculesNature Cell Biology News and Views (01 Feb 2001)

